Clinical Trials
2 trialsNCT01059786 2025-06-12
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT00421174 2021-11-01
BMTCTN0403
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed